StockTipsArenaBeta

BUY Poly Medicure Limited — Deven Mehata, IDBI Capital Markets and Securities

BUYPoly Medicure Limited
Poly Medicure share price target & all analyst calls

byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1–3 months)1 Jul 2026via NDTV Profit (Live)

Entry₹1,687.4Stated
Target₹1,845
Total upside +9.34% (call closed)
Stop loss₹1,615-4.29% risk
Exit₹1,6158 Jul 2026, 12:00 am
Stop-loss hit-4.29%
Follow Deven Mehata for new callsGet alertsWatch POLYMED for new buy/sell callsGet alertsSee 34 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 7:41 am IST
0 supporting1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Poly Medicure received an order from the Office of Divisional Commissioner, Delhi, imposing a stamp duty of Rs. 1 crore and penalty of Rs. 1.5 crore. The company disputes the order and is pursuing leg

BSE · Company Update·16 Jun · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Poly Medicure

All analyst calls on Poly Medicure

More from Deven Mehata, IDBI Capital Markets and Securities

Every call and its outcome